Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 1999;45:795-796; doi:10.1136/gut.45.6.795
Copyright © 1999 BMJ Publishing Group Ltd & British Society of Gastroenterology.
Gut 1999;45:795-796 ( December )

Commentary

See article on page 822

Cryptic messages in FAP

The first 150 words of the full text of this article appear below.

A series of remarkable clinical, epidemiological, and laboratory studies has shown that aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) such as sulindac, can prevent the development of colorectal cancer and cause regression of pre-existing adenomas.1 Aspirin is one of the most potent chemopreventive agents against colorectal cancer. However, its mechanism for causing a reduction in colorectal cancer risk and mortality is unknown.2 The anti-inflammatory properties of NSAIDs are thought to reside in their ability to inhibit prostaglandin production at sites of inflammation.

Cyclooxygenase (COX) is a key enzyme in the production of prostaglandins, and aspirin can inhibit its activity directly. Initially, COX was thought to be a single enzyme, but in 1991 a second COX isoform was discovered (COX-2) which is induced by cytokines, growth factors, and tumour promoters.3 COX-1 is expressed constitutively in many tissues and is inhibited by aspirin and other commonly used NSAIDs. Contrastingly, COX-2 can be induced . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac
J J Keller, G J A Offerhaus, M Polak, S N Goodman, M L Zahurak, L M Hylind, S R Hamilton, and F M Giardiello
Gut 1999 45: 822-828. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Yang, K., Fan, K., Kurihara, N., Shinozaki, H., Rigas, B., Augenlicht, L., Kopelovich, L., Edelmann, W., Kucherlapati, R., Lipkin, M. (2003). Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations. Carcinogenesis 24: 605-611 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs